BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 31339305)

  • 21. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
    Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
    J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
    Milunovic MN; Enyedy É; Nagy NV; Kiss T; Trondl R; Jakupec MA; Keppler BK; Krachler R; Novitchi G; Arion VB
    Inorg Chem; 2012 Sep; 51(17):9309-21. PubMed ID: 22889304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
    Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
    J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
    Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
    Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc(II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity.
    Stacy AE; Palanimuthu D; Bernhardt PV; Kalinowski DS; Jansson PJ; Richardson DR
    J Med Chem; 2016 May; 59(10):4965-84. PubMed ID: 27023111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
    Lovejoy DB; Sharp DM; Seebacher N; Obeidy P; Prichard T; Stefani C; Basha MT; Sharpe PC; Jansson PJ; Kalinowski DS; Bernhardt PV; Richardson DR
    J Med Chem; 2012 Aug; 55(16):7230-44. PubMed ID: 22861499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study.
    Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C
    J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
    Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
    Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo anticancer activity of copper bis(thiosemicarbazone) complexes.
    Palanimuthu D; Shinde SV; Somasundaram K; Samuelson AG
    J Med Chem; 2013 Feb; 56(3):722-34. PubMed ID: 23320568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.
    Leovac VM; Bogdanović GA; Jovanović LS; Joksović L; Marković V; Joksović MD; Denčić SM; Isaković A; Marković I; Heinemann FW; Trifunović S; Đalović I
    J Inorg Biochem; 2011 Nov; 105(11):1413-21. PubMed ID: 21955843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization.
    Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR
    J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu
    Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M
    Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, spectroscopic, anticancer and antibacterial studies of Ni(II) and Cu(II) complexes with 2-carboxybenzaldehyde thiosemicarbazone.
    Chandra S; Vandana
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():333-8. PubMed ID: 24747857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.
    Akladios FN; Andrew SD; Parkinson CJ
    J Biol Inorg Chem; 2016 Dec; 21(8):931-944. PubMed ID: 27645502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Complexation of Thiosemicarbazone Derivatives with Cu (II) Ions on Their Antitumor Activity against Melanoma Cells.
    Pitucha M; Korga-Plewko A; Czylkowska A; Rogalewicz B; Drozd M; Iwan M; Kubik J; Humeniuk E; Adamczuk G; Karczmarzyk Z; Fornal E; Wysocki W; Bartnik P
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc(II) complexes of 2-acetyl pyridine 1-(4-fluorophenyl)-piperazinyl thiosemicarbazone: Synthesis, spectroscopic study and crystal structures - potential anticancer drugs.
    Stanojkovic TP; Kovala-Demertzi D; Primikyri A; Garcia-Santos I; Castineiras A; Juranic Z; Demertzis MA
    J Inorg Biochem; 2010 Apr; 104(4):467-76. PubMed ID: 20102782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes.
    Ajibade PA; Andrew FP; Botha NL; Solomane N
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32781741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.